-
Previous
h/m HIF1a shRNA Lentivirus
$595.00 – $1,195.00
-
Next
h/m SREBP1 shRNA Lentivirus
$595.00 – $1,195.00
h/m HIF2a shRNA Lentivirus
$595.00 – $1,195.00
Validated HIF2a shRNA Lentivirus: High-titer shRNA lentiviral particles specific for human/mouse hypoxia-inducible factor 2 alpha (HIF2a/EPAS1). The shRNA has been validated to meet or exceed 70% HIF2a knockdown efficiency using a specific fluorescence-based method that is more rapid and reliable than qPCR. The shRNA lentivirus is ultra-purified and concentrated to high-titer by PEG precipitation and sucrose gradient centrifugation, and ideal for transducing difficult-to-transfect cells including thawed and/or primary cells. Order a shRNA lentivirus set and receive lentivirus produced from mix of 2 independent shRNAs validated to knockdown the target gene (>70%) plus control lentivirus produced from mix of 2 scrambled shRNA constructs.
Have questions about this product? Need stable cell line instead? Send us a form and we’ll reply the same day: Contact Us
Available Options:
Specifications
Key Advantages:
- Same Cost For Custom Lentivirus – You can receive any combination of reporter (GFP/RFP/Luc/None) and selection marker (puromycin/blasticidin) for this product, without additional cost, by contacting us. To view our complete list of shRNA vectors, click here.
- Superior knockdown – LipExoGen Validated shRNA Lentiviruses are produced using the third generation system and feature novel, optimized shRNA vectors which express a 19-20 bp shRNA, fluorescent (GFP or RFP) or luminescent (luciferase) reporter, and drug-selection marker (puromycin or blasticidin). Taking advantage of a proprietary prediction algorithm developed in-house, validated shRNA constructs are capable of delivering 70% or more knockdown efficiency with less off-target effects compared to longer or mixed-sequence shRNA/siRNAs.
- Superior validation – All of our pre-made shRNA constructs are validated in-house using a specific fluorescence-based method that is more reliable than traditional qPCR. The validation process leverages bicistronic expression of the target mRNA and fluorescent reporter to confirm the efficacy of the shRNA. As knockdown validation can be readout using basic fluorescence microscopy, this low-cost, streamlined approach allows us to provide a superior-quality product at a price comparable or less than the average competitor.
- Superior accuracy – Polyclonal shRNA-transduced stable cells can be established within 10 days and used for downstream applications while preserving more properties of the parental cells. In this way, high-efficiency knockdown from our validated shRNA lentiviral particles can be advantageous over sgRNA CRISPR-Cas9 systems which select for single cell clones.
- Easily identify transduced cells – Validated shRNA constructs contain both fluorescent reporter and drug selection marker, allowing the flexibility to select transduced cells by puromycin/blasticidin or FACS sorting of GFP/RFP. Luciferase reporters are also available for detecting transduced cells in vitro or in vivo using luminescence-based techniques.
Product Data
Figure 1. Knockdown validation for HIF2a-sh-GFP-Puro. HEK293FT cells were co-transfected with human HIF2a-Flag and plasmids for Scr-sh-GFP-Puro, h/m HIF2a-sh2-GFP-Puro, or h/m-HIF2a-sh3-GFP-Puro (green). After 24-36 hours, the cells were fixed and stained for Flag tag (CY3, red) and the cells were observed under the fluorescence microscope to view GFP and CY3 at the same time. GFP represents transfection of the shRNA construct, whereas CY3 marks the relative protein expression of HIF2a. Higher knockdown efficiencies may be possible in stably-transfected cells. Scr-sh, scrambled shRNA. When you order an shRNA “set” from us, you receive combination of sh2 and sh3 for this product. HIF2a-Flag constructs featured here are also available upon request, for more information please contact us.
Details
LSV-0005 | |
EPAS1 | |
endothelial PAS domain protein 1 | |
NM_001430 | |
Human/mouse |
Recommended Control
Scrambled shRNA Control Lentivirus (mix of two independent shRNAs), Scr-sh-GFP-Puro (LSV-0024-2S)
Related Products
Hypoxia/HIF Pathway:
HIF1a shRNA Lentivirus (Human/mouse)
HIF1a Transcriptional Reporter Lentivirus (Human/mouse)
HIF2a Transcriptional Reporter Lentivirus (Human/mouse)
Hif1a-PPN ORF cDNA Lentivirus (Mouse)
Custom Orders
If you require a modification to one of our products (for example, change in reporter or other vector component), please request a custom order. We provide a variety of fast and efficient services for the production of high-quality, custom lentiviral particles on demand, usually for the same or comparable price as the listed item.
Or, send us your cells and we will establish a stable shRNA cell line for you using this product. Learn more.
The cDNA lentivirus corresponding to this product is also available upon request, comparable price.
I want to:
Additional Information
Additional Information
EPAS1 | |
endothelial PAS domain protein 1 | |
n | NM_001430 |
Homo sapiens/mus musculus | |
Alias | Endothelial PAS Domain Protein 1; Endothelial PAS Domain-Containing Protein; Class E Basic Helix-Loop-Helix Protein 73; Basic-Helix-Loop-Helix-PAS Protein MOP2; PAS Domain-Containing Protein 2; Member Of PAS Protein 2; HIF-1-Alpha-Like Factor; HIF-2-Alpha; HIF2-Alpha; BHLHe73; EPAS-1; HIF2A; PASD2; MOP2; HLF; Hypoxia-Inducible Factor 2 Alpha; Hypoxia-Inducible Factor 2-Alpha; HIF-1 Alpha-Like Factor; HIF-1alpha-Like Factor; BHLHE73; ECYT4 |
Annotation Page | https://www.ncbi.nlm.nih.gov/gene/?term=NM_001430 |
Gene IDs | HGNC:HGNC:3374 Ensembl:ENSG00000116016 MIM:603349 |
Entrez Gene Summary | “This gene encodes a transcription factor involved in the induction of genes regulated by oxygen, which is induced as oxygen levels fall. The encoded protein contains a basic-helix-loop-helix domain protein dimerization domain as well as a domain found in proteins in signal transduction pathways which respond to oxygen levels. Mutations in this gene are associated with erythrocytosis familial type 4. [provided by RefSeq, Nov 2009]” |